2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
195
Neoplasm Metastasis
22
Prostatic Neoplasms, Castration-Resistant
20
Breast Neoplasms
19
Neoplasms
18
Metastatic Castration Resistant Prostate Cancer
10
Prostate Cancer Metastatic
7
Metastatic Castration-Resistant Prostate Cancer
7
Triple Negative Breast Neoplasms
6
Metastatic Castration-resistant Prostate Cancer
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Pancreatic Neoplasms
5
Colorectal Neoplasms
5
Castration-resistant Prostate Cancer
5
Carcinoma, Non-Small-Cell Lung
5
Melanoma
4
Carcinoma, Hepatocellular
4
Bulbo-Spinal Atrophy, X-Linked
4
Adenocarcinoma
4
Urinary Bladder Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Small Cell Lung Carcinoma
3
Prostate Adenocarcinoma
3
Ovarian Neoplasms
3
Carcinoma, Renal Cell
3
mCRPC
2
Uterine Cervical Neoplasms
2
Recurrence
2
Prostatic Diseases
2
Non-metastatic Castration-resistant Prostate Cancer
2
Interventions
Therapeutics
31
Psychiatric Rehabilitation
27
Surveys and Questionnaires
15
Cognitive Behavioral Therapy
12
Early Intervention, Educational
10
Psilocybin
9
Ketamine
9
Methods
8
Saline Solution
7
Yoga
6
Mindfulness-Based Cognitive Therapy
6
Interviews as Topic
6
Esketamine
6
Counseling
6
Psychosocial Intervention
5
Mindfulness
5
Methylphenidate
5
Escitalopram
5
Educational Status
5
Behavior Therapy
5
Acupuncture Therapy
5
Palliative Care
4
Exercise Therapy
4
Exercise
4
Control Groups
4
Caregivers
4
Standard of Care
3
Psychotherapy
3
Niacin
3
Mindfulness-Based Stress Reduction
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Depression
×
enzalutamide
×
Clear all
NCT07181122
2026-04-28
PRO-MIND
Ankara Etlik City Hospital
Recruiting
102 enrolled